Somatostatin Analogues in the Treatment of Neuroendocrine Tumors: Past, Present and Future

In recent decades, the incidence of neuroendocrine tumors (NETs) has steadily increased. Due to the slow-growing nature of these tumors and the lack of early symptoms, most cases are diagnosed at advanced stages, when curative treatment options are no longer available. Prognosis and survival of pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Stueven, Anna Kathrin, Kayser, Antonin, Wetz, Christoph, Amthauer, Holger, Wree, Alexander, Tacke, Frank, Wiedenmann, Bertram, Roderburg, Christoph, Jann, Henning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627451/
https://www.ncbi.nlm.nih.gov/pubmed/31234481
http://dx.doi.org/10.3390/ijms20123049

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627451/
https://www.ncbi.nlm.nih.gov/pubmed/31234481
http://dx.doi.org/10.3390/ijms20123049

Ejemplares similares